
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.570 | 8.570 | 0.000 |
Shares | 93.230 | 93.230 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 48.591 | 34.289 |
Price to Book | 5.643 | 4.383 |
Price to Sales | 8.387 | 6.568 |
Price to Cash Flow | 33.270 | 25.092 |
Dividend Yield | 0.902 | 1.464 |
5 Years Earnings Growth | 3.193 | 6.365 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.780 | 93.904 |
Consumer Defensive | 3.220 | 4.796 |
Number of long holdings: 37
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
APT Medical | CNE100004C45 | 9.23 | 316.73 | +1.05% | |
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 8.62 | 53.46 | -0.56% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 8.62 | 375.30 | +3.43% | |
Kelun Pharm A | CNE100000PW7 | 8.04 | 36.73 | +1.05% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 8.01 | 113.01 | +4.43% | |
InnoCare Pharma | CNE100005P56 | 6.69 | 28.52 | +2.81% | |
Salubris Pharm A | CNE100000FW8 | 6.22 | 60.35 | +1.67% | |
Shanghai Aohua Photoelectricity Endoscope | CNE100004ZJ5 | 5.16 | 51.78 | +3.04% | |
BeOne Medicines | CNE100005XT6 | 4.94 | 306.90 | +1.95% | |
Youcare Pharmaceutical Group Co | CNE100005XQ2 | 4.61 | 22.15 | -2.64% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fullgoal Tianhui Selected Growth Mi | 23.54B | 14.06 | -0.60 | 8.13 | ||
Fullgoal CSI 300 Strengthen Fund | 7.92B | 15.79 | 4.92 | 7.01 | ||
Fullgoal Emerging Industry Stock Fd | 6.79B | 60.74 | 21.19 | 11.36 | ||
Fullgoal China Secs new energy veh | 6.54B | 23.67 | -9.33 | 5.94 | ||
Fullgoal Tianding China Securities | 5.8B | 5.29 | 6.70 | 7.96 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review